
Singapore · Research startup
CHITOSE Group is a collective of biotechnology companies focused on advancing the bioeconomy.
Funding reportedLast round: Debt financing
Follow CHITOSE Group and see its new rounds in your feed.Start following
CHITOSE Group is a collective of biotechnology companies focused on advancing the bioeconomy.
The group aims to shift society from fossil fuel reliance to a sustainable, biomass-based economy by utilizing microorganisms, cells, and microbiota. With 11 biotechnology startups primarily located in Japan and Southeast Asia, CHITOSE Group is dedicated to creating sustainable businesses through collaboration and innovation. The group engages in extensive research and development across various fields, including microalgae, fermentation, and agriculture. Key initiatives include sustainable microalgae fuel production, medical cell lines for pharmaceuticals, microbiome analysis for health and agriculture, and the supply of high-quality organic fertilizers. CHITOSE Group partners with major corporations in the pharmaceutical, food, chemical, agricultural, and energy sectors to drive its mission of fostering a sustainable future.
Funding, as reported
From CHITOSE Group's own website: 5 on the team.
AdvisersMitsuru Furusawa Ph.D.Sakayu Shimizu Ph.D.Yoshiaki Fujimori
What they build
Known for
health carebiotechnology researchdistributionmanufacturingtropical agriculture biotecheducationinformation technology & servicessoil microbiota analysisfinancial servicescircular manufacturingfinancemicroalgae-based resource circulationbioindustryfood productionagribusinessenvironmental services
Built with from their website
Contact Form 7Google Tag ManagerGoogle App EngineWordPress.orgGoogle Firebase Realtime DatabaseGoogle CloudGoogle Cloud RunYouTubeCloudflare DNSGoogle Workspace
CloudFlareMax Mega MenuViewport MetaGoogle AnalyticsCloudflare Rocket LoaderAIOSEOCloudflare Browser InsightsGoogle Cloud Storage
Add your raise, your deck and your story, and put CHITOSE Group in front of investors. Or tell us what we have wrong.